Company: BDRX
Filing Date: 2025-09-26
Form Type: F-3
Source: 0001214659-25-014255
Chunk: 16

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-09-26
Form: F-3
Chunk 16
---
 acquisitions into our own; |

| 8 |

| · | cybersecurity and other cyber incidents; |

| · | industry trends; |

| · | the impact of government laws and regulations; |

| · | regulatory, economic and political developments in the United Kingdom, the European Union, the United        
 States and other foreign countries, including any impact from the United Kingdom leaving the European Union; |

| · | the difficulties doing business internationally; |

| · | the ownership of our Ordinary Shares and Depositary Shares; |

| · | our ability to continue to meet the listing criteria required to remain listed on The NASDAQ Capital Market; |

| · | our ability to recruit or retain key scientific or management personnel or to retain our senior management; |

| · | the impact and costs and expenses of any litigation we may be subject to now or in the future; and |

| · | the performance of third parties, including joint venture partners, our collaborators, third-party suppliers 
 and parties to our licensing agreements.                                                                     |

We
may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue
reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations
disclosed in the forward-looking statements we make. We have included important cautionary statements in this prospectus or in the documents
incorporated by reference in this prospectus, particularly in the “Risk Factors” section, that we believe could cause actual
results or events to differ materially from the forward-looking statements that we make. For a summary of such factors, please refer to
the section titled “Risk Factors” in this prospectus, as updated and supplemented by the discussion of risks and uncertainties
under “Risk Factors” contained in any supplements to this prospectus and in our most recent Annual Report on Form 20-F, as
revised or supplemented by our subsequent periodic reports filed under the Exchange Act, as well as any amendments thereto, as filed with
the SEC and which are incorporated herein by reference. The information contained in this document is believed to be current as of the
date of this document. We do not intend to update any of the forward-looking statements after the date of this document to conform these
statements to actual results or to changes in our expectations, except as required by law.

In
light of these assumptions, risks and uncertainties, the results and events discussed in the forward-looking statements contained in this
prospectus or in any